MDMB-CHMINACA

MDMB-CHMINACA (also known as MDMB(N)-CHM) is an indazole-based synthetic cannabinoid.

It is potent agonist of the CB1 receptor, and is sold online as a designer drug. Because of this, this drug has great binding affinity.

Pfizer invented it in 2008. it become one of the most potent cannabinoid agonists known in the market.

AB-CHMINACA is offered on the Internet either as ‘herbal mixtures’, as a powder, or in a liquid used in e-cigarette devices.
The primary route of administration to be inhalation. Smoking as herbal mixtures using vaping tubes gives you a great experience.